logo
episode-header-image
Feb 2010
47m 27s

Is there a healthy future for Big Pharma...

OXFORD UNIVERSITY
About this episode
Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. The Pharmaceutical industry has been through a period of unprecedented growth in the last three decades, fue ... Show More
Up next
Jun 2009
A Pharma perspective on healthcare needs and innovation in drug discovery
The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. The Green Templeton Lectures 2009 explored the theme 'Addicted to Big Pharma? Reconcilin ... Show More
57m 58s
Jun 2009
Pharmaceutical Companies, Government and Society
This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment. 
37m 8s
May 2009
Pharmaceutical Industry: Origin and Evolution
Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. The strong focus on British companies is not exclusiv ... Show More
55m 48s
Recommended Episodes
Apr 2025
China's game-changing pharmaceutical and biotech industry
China is fast becoming a major player in the global pharmaceutical and biotech industries. Once focused primarily on generic and me-too drugs, Chinese companies are now making headlines with innovative breakthroughs in oncology and gene therapy. Foreign investors are taking notic ... Show More
21m 1s
Sep 2023
The intersection of technology and healthcare
Private markets have grown significantly over the past few years, fueled by scientific breakthroughs and technological innovation. Our experts discuss biotechnology, artificial intelligence and healthcare valuation trends, how venture capitalists and startups are navigating the c ... Show More
25m 15s
Jan 2024
JP Morgan Healthcare Conference Highlights
Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. Deidre Woollard caught up with Motley Fool biotech analyst Karl Thiel to discuss: - Biogen’s next shot at an Alzheimer’s treatment. - Why companies can’t “muscle their way” i ... Show More
26m 16s
Jun 2020
Learning to Love Big Pharma
Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How ... Show More
13m 27s
Jul 2022
Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ... Show More
15m 33s
Jun 2014
The Medicalisation of Depression
In an age where pharmacy is a global industry, stigma and medicine are now in the position where they are the co-constructors of illness on one hand and mutually exclusive players on the other. Professor Sonia Ryang (Anthropology and International Studies, University of Iowa) ext ... Show More
35m 32s
Dec 2018
Healthcare: China’s Biotech Revolution
China’s biotech industry is booming. Driven by vast government funding and Western partnerships, the country is introducing new commercial drugs at a faster pace than ever before. But could controversial topics such as human genetic engineering derail its accelerated growth? Shan ... Show More
36m 3s
Jun 2021
Marvellous medicine
During the pandemic, the world witnessed how fast medicine can advance with an abundance of cash and collaboration. Is progress at this speed and cost sustainable? Sandra Kanthal asks if drug development is something which should still take decades, or have we learned how to perm ... Show More
23m 36s
Jan 2020
Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ... Show More
12m 36s